Is Cancer a Risk for RA Patients?

Published Online: Tuesday, July 1, 2003

Swedish researchers conducted a study to determine whether the increased risk of malignant lymphomas in patients with rheumatoid arthritis (RA) was the result of environmental and genetic factors rather than a consequence of the disease itself. For their study, the researchers looked at 76,527 patients hospitalized with RA between 1964 and 1999. The participants were followed for >3 decades, and any occurrences of cancer were reported. In addition, to rule out genetic factors, the scientists looked at the incidence of malignant lymphomas in the first-degree relatives of the patients.

The results showed a significant increase in the risk of malignant lymphomas in RA patients.

The investigators concluded that lymphomas complicating RA appear to be a direct consequence of the inflammation or its treatment. There was no increase in the risk of cancer among first-degree relatives with RA.

Latest Articles
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Latest Issues